These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924 [TBL] [Abstract][Full Text] [Related]
10. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer. Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189 [TBL] [Abstract][Full Text] [Related]
11. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Tanaka F; Otake Y; Nakagawa T; Kawano Y; Miyahara R; Li M; Yanagihara K; Inui K; Oyanagi H; Yamada T; Nakayama J; Fujimoto I; Ikenaka K; Wada H Cancer Res; 2001 Feb; 61(4):1666-70. PubMed ID: 11245481 [TBL] [Abstract][Full Text] [Related]
13. [Expression of HDGF and its implication in stage I non-small cell lung cancer]. Zhou SJ; Xu SF; Zhang HQ; Liu ZD Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933 [TBL] [Abstract][Full Text] [Related]
15. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294 [TBL] [Abstract][Full Text] [Related]
16. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA. Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385 [TBL] [Abstract][Full Text] [Related]
17. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer. Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145 [TBL] [Abstract][Full Text] [Related]
19. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Sakata T; Ferdous G; Tsuruta T; Satoh T; Baba S; Muto T; Ueno A; Kanai Y; Endou H; Okayasu I Pathol Int; 2009 Jan; 59(1):7-18. PubMed ID: 19121087 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers. Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]